| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lin Xu, Rong Xue, Zhu Ai, Yaqin Huang, Xuan Liu, Linlin Wang, Danqi Liang, Zuojun Wan. Resting-State Functional Magnetic Resonance Imaging as an Indicator of Neuropsychological Changes in Type 1 Narcolepsy. Academic radiology. 2023-10-11. PMID:37821344. |
to explore indicators of neuropsychological changes in patients with type 1 narcolepsy (nt1) using resting-state functional magnetic resonance imaging (rs-fmri). |
2023-10-11 |
2023-10-15 |
Not clear |
| Mariana Fernandes, Matteo Spanetta, Fabio Placidi, Francesca Izzi, Francesco Negri, Marzia Nuccetelli, Sergio Bernardini, Nicola Biagio Mercuri, Claudio Liguor. A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2. Physiology & behavior. 2023-10-06. PMID:37802459. |
since csf lactate concentrations fluctuate according to the sleep-wake cycle with higher levels during wakefulness and lower levels during sleep, as documented in animal model studies, the present study aimed at quantifying the csf lactate levels in patients with narcolepsy type 1 (nt1) and 2 (nt2), two sleep disorders featured by excessive daytime sleepiness (eds). |
2023-10-06 |
2023-10-15 |
Not clear |
| Qingqing Zhan, Lili Wang, Nan Liu, Yuqing Yuan, Liying Deng, Yongmin Ding, Fen Wang, Jian Zhou, Liang Xi. Serum metabolomics study of narcolepsy type 1 based on ultra-performance liquid chromatography-tandem mass spectrometry. Amino acids. 2023-09-09. PMID:37689600. |
furthermore, narcolepsy type 1 (nt1) has serious negative impacts on an individual's health, society, and the economy. |
2023-09-09 |
2023-10-07 |
Not clear |
| Marco Menchetti, Francesco Biscarini, Giombattista Sallemi, Elena Antelmi, Christian Franceschini, Stefano Vandi, Giulia Neccia, Valentina Baldini, Giuseppe Plazzi, Fabio Pizz. Phenomenology and psychiatric correlates of pseudocataplexy. Sleep. 2023-09-08. PMID:37682005. |
pseudocataplexy is a rare functional neurological disorder that mimics cataplexy, pathognomonic for narcolepsy type 1 (nt1). |
2023-09-08 |
2023-10-07 |
Not clear |
| L Barateau, F Pizza, S Chenini, L Peter-Derex, Y Dauvillier. Narcolepsies, update in 2023. Revue neurologique. 2023-08-27. PMID:37634997. |
narcolepsy type 1 (nt1) and type 2 (nt2), also known as narcolepsy with and without cataplexy, are sleep disorders that benefited from major scientific advances over the last two decades. |
2023-08-27 |
2023-09-07 |
Not clear |
| Eva Wiberg Torstensen, Niels Christian Haubjerg Østerby, Birgitte Rahbek Kornum, Benedikte Wanscher, Emmanuel Mignot, Mads Barløse, Poul Jørgen Jennu. Repeated polysomnography and multiple sleep latency test in narcolepsy type 1 and other hypersomnolence disorders. Sleep medicine. vol 110. 2023-08-06. PMID:37544279. |
psg and the mslt are moderately reliable at diagnosing narcolepsy type 1 (nt1) but unreliable for diagnosing narcolepsy type 2 (nt2). |
2023-08-06 |
2023-08-14 |
Not clear |
| Chenyang Li, Karen Spruyt, Liang Xie, Chi Zhang, Zhifei Xu, Fang Ha. Development and validation of the narcolepsy severity scale in school aged children. Sleep medicine. vol 110. 2023-07-30. PMID:37517284. |
to develop and psychometrically test the pediatric narcolepsy severity scale (p-nss) for pediatric with narcolepsy type 1 (nt1). |
2023-07-30 |
2023-08-14 |
Not clear |
| Ling Shan, Suzan Linssen, Zoe Harteman, Fleur den Dekker, Lamis Shuker, Rawien Balesar, Nicole Breesuwsma, Jasper Anink, Jingru Zhou, Gert Jan Lammers, Dick F Swaab, Rolf Froncze. Activated wake systems in narcolepsy type 1. Annals of neurology. 2023-07-03. PMID:37395722. |
narcolepsy type 1 (nt1) is assumed to be caused solely by a lack of hypocretin (orexin) neurotransmission. |
2023-07-03 |
2023-08-14 |
Not clear |
| Sara Casale, Valentina Assirelli, Fabio Pizza, Antonio Balsamo, Monia Gennari, Andrea Pession, Giuseppe Plazzi, Alessandra Cassi. Auxological and endocrine findings in narcolepsy type 1: seventeen-year follow-up from a pediatric endocrinology center. Frontiers in endocrinology. vol 14. 2023-07-03. PMID:37396177. |
narcolepsy type 1 (nt1) is a rare hypersomnia of central origin linked to hypocretin deficiency, most frequently arising at pediatric age. |
2023-07-03 |
2023-08-14 |
Not clear |
| Roland S Liblau, Daniela Latorre, Birgitte R Kornum, Yves Dauvilliers, Emmanuel J Migno. The immunopathogenesis of narcolepsy type 1. Nature reviews. Immunology. 2023-07-03. PMID:37400646. |
narcolepsy type 1 (nt1) is a chronic sleep disorder resulting from the loss of a small population of hypothalamic neurons that produce wake-promoting hypocretin (hcrt; also known as orexin) peptides. |
2023-07-03 |
2023-08-14 |
Not clear |
| Kugui Yoshida-Tanaka, Mihoko Shimada, Yoshiko Honda, Akihiro Fujimoto, Katsushi Tokunaga, Makoto Honda, Taku Miyagaw. Narcolepsy type I-associated DNA methylation and gene expression changes in the human leukocyte antigen region. Scientific reports. vol 13. issue 1. 2023-06-28. PMID:37380713. |
narcolepsy type 1 (nt1) is caused by a loss of hypothalamic orexin-producing cells, and autoreactive cd4 |
2023-06-28 |
2023-08-14 |
human |
| Wei-Chih Chin, Yu-Shu Huang, I Tang, Pin-Yi Lee, Chih-Huan Wang, Kuo-Yu Cha. Impact of Taiwan's 2021 COVID-19 lockdown on the symptom severity and quality of life of patients with narcolepsy. Sleep and biological rhythms. 2023-06-26. PMID:37363640. |
patients with type 1 and type 2 narcolepsy (nt1 and nt2, respectively) aged 6-40 years were retrospectively recruited from our narcolepsy cohort study. |
2023-06-26 |
2023-08-14 |
Not clear |
| Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J Thorpy, Anne Marie Morse, Asim Roy, Jordan Dubow, Jennifer Gudema. Efficacy of Once-Nightly Sodium Oxybate (FT218) in Narcolepsy Type 1 and Type 2: Post Hoc Analysis From the Phase 3 REST-ON Trial. Sleep. 2023-05-29. PMID:37246913. |
post hoc analyses from the phase 3 rest-on trial evaluated efficacy of extended-release once-nightly sodium oxybate (on-sxb; ft218) vs placebo for daytime sleepiness and disrupted nighttime sleep in narcolepsy type 1 (nt1) and 2 (nt2). |
2023-05-29 |
2023-08-14 |
Not clear |
| Samantha Mombelli, François Ricordeau, Léa Gillard, Rosa Lecca, Tiphaine Vidal, Bruno Pereira, Patricia Beudin, Nicolas Vitello, Helene Bastuji, Laure Peter-Derex, Maria Livia Fantin. Psychobehavioural profile in narcolepsy type 1 with and without REM sleep behaviour disorder. Journal of sleep research. 2023-05-24. PMID:37222001. |
rem sleep behaviour disorder (rbd) is common in narcolepsy type 1 (nt1). |
2023-05-24 |
2023-08-14 |
Not clear |
| Louise Piilgaard, Laura Rose, Jessica L Justinussen, Camille Gylling Hviid, René Lemcke, Petrine Wellendorph, Birgitte Rahbek Kornu. Non-invasive detection of narcolepsy type I phenotypical features and disease progression by continuous home-cage monitoring of activity in two mouse models: the HCRT-KO and DTA model. Sleep. 2023-05-20. PMID:37210587. |
narcolepsy type 1 (nt1) is a neurological disorder caused by disruption of hypocretin (hcrt; or orexin) neurotransmission leading to fragmented sleep/wake states, excessive daytime sleepiness (eds), and cataplexy (abrupt muscle atonia during wakefulness). |
2023-05-20 |
2023-08-14 |
mouse |
| Hanna M Ollila, Eilon Sharon, Ling Lin, Nasa Sinnott-Armstrong, Aditya Ambati, Selina M Yogeshwar, Ryan P Hillary, Otto Jolanki, Juliette Faraco, Mali Einen, Guo Luo, Jing Zhang, Fang Han, Han Yan, Xiao Song Dong, Jing Li, Jun Zhang, Seung-Chul Hong, Tae Won Kim, Yves Dauvilliers, Lucie Barateau, Gert Jan Lammers, Rolf Fronczek, Geert Mayer, Joan Santamaria, Isabelle Arnulf, Stine Knudsen-Heier, May Kristin Lyamouri Bredahl, Per Medbøe Thorsby, Giuseppe Plazzi, Fabio Pizza, Monica Moresco, Catherine Crowe, Stephen K Van den Eeden, Michel Lecendreux, Patrice Bourgin, Takashi Kanbayashi, Francisco J Martínez-Orozco, Rosa Peraita-Adrados, Antonio Benetó, Jacques Montplaisir, Alex Desautels, Yu-Shu Huang, Poul Jennum, Sona Nevsimalova, David Kemlink, Alex Iranzo, Sebastiaan Overeem, Aleksandra Wierzbicka, Peter Geisler, Karel Sonka, Makoto Honda, Birgit Högl, Ambra Stefani, Fernando Morgadinho Coelho, Vilma Mantovani, Eva Feketeova, Mia Wadelius, Niclas Eriksson, Hans Smedje, Pär Hallberg, Per Egil Hesla, David Rye, Zerrin Pelin, Luigi Ferini-Strambi, Claudio L Bassetti, Johannes Mathis, Ramin Khatami, Adi Aran, Sheela Nampoothiri, Tomas Olsson, Ingrid Kockum, Markku Partinen, Markus Perola, Birgitte R Kornum, Sina Rueger, Juliane Winkelmann, Taku Miyagawa, Hiromi Toyoda, Seik-Soon Khor, Mihoko Shimada, Katsushi Tokunaga, Manuel Rivas, Jonathan K Pritchard, Neil Risch, Zoltan Kutalik, Ruth O'Hara, Joachim Hallmayer, Chun Jimmie Ye, Emmanuel J Migno. Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy. Nature communications. vol 14. issue 1. 2023-05-15. PMID:37188663. |
narcolepsy type 1 (nt1) is caused by a loss of hypocretin/orexin transmission. |
2023-05-15 |
2023-08-14 |
Not clear |
| Ikram Ayoub, Yves Dauvilliers, Lucie Barateau, Thaïs Vermeulen, Emmanuelle Mouton-Barbosa, Marlène Marcellin, Anne Gonzalez-de-Peredo, Catharina C Gross, Abdelhadi Saoudi, Roland Libla. Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system. Frontiers in immunology. vol 14. 2023-05-01. PMID:37122721. |
narcolepsy type 1 (nt1) is a rare, chronic and disabling neurological disease causing excessive daytime sleepiness and cataplexy. |
2023-05-01 |
2023-08-14 |
Not clear |
| Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Kimio Tohyama, Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike, Haruhide Kimur. The Journal of pharmacology and experimental therapeutics. 2023-03-31. PMID:37001988. |
loss of orexin neurons is associated with narcolepsy type 1 (nt1), which is characterized by multiple symptoms including excessive daytime sleepiness and cataplexy. |
2023-03-31 |
2023-08-14 |
mouse |
| Akeem Sanni, Mona Goli, Jingfu Zhao, Junyao Wang, Chloe Barsa, Samer El Hayek, Farid Talih, Bartolo Lanuzza, Firas Kobeissy, Giuseppe Plazzi, Monica Moresco, Stefania Mondello, Raffaele Ferri, Yehia Mechre. LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1. Biomolecules. vol 13. issue 3. 2023-03-29. PMID:36979356. |
narcolepsy type 1 (nt1) is the most common type of narcolepsy known to be caused by the loss of specific neurons responsible for producing peptide neurotransmitters (orexins/hypocretins), resulting in a sleep-wake cycle disorder. |
2023-03-29 |
2023-08-14 |
human |
| Karin Janssens, Pauline Amesz, Yvonne Nuvelstijn, Claire Donjacour, Danielle Hendriks, Els Peeters, Laury Quaedackers, Nele Vandenbussche, Sigrid Pillen, Gert Jan Lammer. School Problems and School Support for Children with Narcolepsy: Parent, Teacher, and Child Reports. International journal of environmental research and public health. vol 20. issue 6. 2023-03-29. PMID:36982084. |
to assess problems faced by children with type 1 narcolepsy (nt1) at school and obtain insight into potential interventions for these problems. |
2023-03-29 |
2023-08-14 |
Not clear |